Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulanermin + Rituximab in Relapsed Follicular Lymphoma
NCT00400764Phase 2Terminated
- Sponsor
- Genentech
- Start
- Jun 2006
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of dulanermin in follicular lymphoma (FL), sponsored by Genentech. Started Jun 2006; status: terminated.
02
Drugs
dulanermin
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00400764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400764.